##gff-version 3
##sequence-region Q9H4L5 1 887
Q9H4L5	UniProtKB	Chain	1	887	.	.	.	ID=PRO_0000100371;Note=Oxysterol-binding protein-related protein 3	
Q9H4L5	UniProtKB	Domain	51	146	.	.	.	Note=PH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00145	
Q9H4L5	UniProtKB	Motif	161	167	.	.	.	Note=FFAT 1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25447204;Dbxref=PMID:25447204	
Q9H4L5	UniProtKB	Motif	450	454	.	.	.	Note=FFAT 2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25447204;Dbxref=PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	16	16	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9H4L5	UniProtKB	Modified residue	34	34	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163;Dbxref=PMID:19369195,PMID:23186163	
Q9H4L5	UniProtKB	Modified residue	200	200	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9H4L5	UniProtKB	Modified residue	251	251	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q9H4L5	UniProtKB	Modified residue	265	265	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:25447204;Dbxref=PMID:23186163,PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:25447204;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163,PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9H4L5	UniProtKB	Modified residue	320	320	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:25447204;Dbxref=PMID:23186163,PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	323	323	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25447204;Dbxref=PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	371	371	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25447204;Dbxref=PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	372	372	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:25447204;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163,PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	410	410	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:25447204;Dbxref=PMID:18669648,PMID:18691976,PMID:19369195,PMID:20068231,PMID:23186163,PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	425	425	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9H4L5	UniProtKB	Modified residue	437	437	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18088087,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:25447204;Dbxref=PMID:18088087,PMID:18691976,PMID:19369195,PMID:23186163,PMID:25447204	
Q9H4L5	UniProtKB	Modified residue	440	440	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9H4L5	UniProtKB	Alternative sequence	259	289	.	.	.	ID=VSP_008219;Note=In isoform 1b%2C isoform 1d%2C isoform 2b and isoform 2d. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12590732;Dbxref=PMID:12590732	
Q9H4L5	UniProtKB	Alternative sequence	387	422	.	.	.	ID=VSP_008220;Note=In isoform 1c%2C isoform 1d%2C isoform 2c and isoform 2d. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12590732;Dbxref=PMID:12590732	
Q9H4L5	UniProtKB	Alternative sequence	584	631	.	.	.	ID=VSP_008221;Note=In isoform 2a%2C isoform 2b%2C isoform 2c and isoform 2d. YVAAFAISAYASSYYRAGSKPFNPVLGETYECIREDKGFQFFSEQVSH->RSQPSLATVQPRSPSHEAIHGAHQRDSPCSLRFHFDCSVNRFITQSCLASSAWLFPVTL;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12590732;Dbxref=PMID:12590732	
Q9H4L5	UniProtKB	Alternative sequence	632	887	.	.	.	ID=VSP_008222;Note=In isoform 2a%2C isoform 2b%2C isoform 2c and isoform 2d. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12590732;Dbxref=PMID:12590732	
Q9H4L5	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_053548;Note=M->V;Dbxref=dbSNP:rs11768296	
Q9H4L5	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Abolishes plasma membrane targeting and nuclear localization. K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16143324;Dbxref=PMID:16143324	
Q9H4L5	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Abolishes plasma membrane targeting and nuclear localization. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16143324;Dbxref=PMID:16143324	
Q9H4L5	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Abolishes plasma membrane targeting and nuclear localization. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16143324;Dbxref=PMID:16143324	
Q9H4L5	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Abolishes plasma membrane targeting and nuclear localization. R->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16143324;Dbxref=PMID:16143324	
Q9H4L5	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Decreases plasma membrane targeting and nuclear localization. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16143324;Dbxref=PMID:16143324	
Q9H4L5	UniProtKB	Mutagenesis	162	167	.	.	.	Note=No effect on interaction with VAPA. FFSGST->AAAAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25447204;Dbxref=PMID:25447204	
Q9H4L5	UniProtKB	Mutagenesis	451	453	.	.	.	Note=Reduces VAPA binding. Abolishes association with endoplasmic reticulum. FFD->VVV;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16143324,ECO:0000269|PubMed:25447204;Dbxref=PMID:16143324,PMID:25447204	
